Unum Therapeutics' Series B Round

Unum Therapeutics raised a round of funding on June 11, 2015.

Unum Therapeutics is a clinical stage biopharmaceutical company developing cellular immunotherapies for the treatment of many different cancers. Unum develops combination cancer therapies using recent…

Articles about Unum Therapeutics' Series B Round: